Patient organizations are concerned about the lack of funding for additional research on long covid treatments as the Dutch Parliament prepares to vote on an amendment for €21 million in research budget. With no majority in sight, experts warn that it could jeopardize short-term care for nearly half a million patients suffering from significant symptoms. While clinics in several cities begin treating symptoms, clinical research is essential for legitimizing these treatments to insurance providers, making the need for funding especially pressing.